Another protein, known as exosomal annexin A6 (AnxA6), has been found to be highly expressed in gemcitabine‐resistant TNBC cells and induces tumour resistance through the inhibition of EGFR ubiquitination and degradation. This evidence concerns the gene ANXA6 and neoplasm.